Skip to main content
Premium Trial:

Request an Annual Quote

NextGen, BD Clontech, PrecisionMed


NextGen Sciences has begun rolling out its fully automated 2-dimensional electrophoresis system, the a2DE, which the company bills as being the only system that can run 2D gel electrophoresis without supervision or intervention. NextGen also launched its expressionfactory technology, which enables researchers to perform systematic, automated, and high throughput protein expression and purification.

The launches coincide with the opening of NextGen’s first international office, NextGen Sciences, in Bedford, Mass.,which the company announced last week. The facility will support the company’s customer base in the United States, and will provide NextGen Sciences with a sales, support, and manufacturing base for their technologies outside the UK.

BD Clontech has launched its RNA/cDNA Quality Assay, which is designed to determine the quality of human RNA and cDNA samples using reverse transcription and PCR. The company said the tool can enable researchers to obtain the representation of full-length transcripts for experiments with cDNA libraries, RACE-ready cDNAs, or microarray cDNA probes.

PrecisionMed has launched a new PrecisionMed Sample Bank collection in late-onset Alzheimer’s disease for genetics, proteomics, and molecular diagnostics research. The product comprises data that includes the following rating scales: Clinical Dementia Rating, Mini Mental Status Exam and the ADAS-cog, and detailed demographic information, PrecisionMed said in a statement. This controlled collection will supplement an existing Alzheimer’s disease sample collection, which includes matched control subjects collected over the past two years and stored in the PrecisionMed sample bank. PrecisionMed’s sample bank is a repository of human blood, DNA, RNA, sera, plasma, and other body fluid linked to anonymous and audited clinical data.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more